IL-15 and HIV infection: lessons for immunotherapy and vaccination

Curr HIV Res. 2005 Jul;3(3):261-70. doi: 10.2174/1570162054368093.

Abstract

IL-15 is a pleiotropic and multifunctional cytokine that has a diverse array of distinct biological effects in the body. It plays a crucial role in host defense from viral and non-viral intracellular pathogens. The cytokine is essential for the development and differentiation of NK cells and for homeostatic expansion of CD8+ memory T cells, NKT cells and certain subsets of intestinal intra-epithelial lymphocytes (iIEL). It acts as a survival factor and inhibits spontaneous apoptosis in T, B and NK cells by increasing expression of different anti-apoptotic proteins. Several studies have shown that IL-15 production is compromised in HIV-infected AIDS patients and exogenous IL-15 drastically enhances functions of immune cells from these patients. Considering these distinct immune enhancing effects, relative safety in animal models, and minimal effects on HIV replication, IL-15 may represent a better cytokine for immune reconstitution in these patients. Furthermore, IL-15 may also act as a better adjuvant in eliciting antiviral immunity in anti-HIV vaccine strategies.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • AIDS Vaccines / therapeutic use
  • Animals
  • Cytokines / metabolism
  • Cytokines / therapeutic use
  • HIV Infections / immunology*
  • HIV Infections / therapy*
  • Humans
  • Immunologic Factors / therapeutic use
  • Immunotherapy
  • Interleukin-15 / biosynthesis
  • Interleukin-15 / immunology
  • Interleukin-15 / therapeutic use*
  • Interleukin-2 / therapeutic use
  • Receptors, Interleukin-15
  • Receptors, Interleukin-2 / chemistry
  • Receptors, Interleukin-2 / immunology
  • Safety

Substances

  • AIDS Vaccines
  • Cytokines
  • IL15RA protein, human
  • Immunologic Factors
  • Interleukin-15
  • Interleukin-2
  • Receptors, Interleukin-15
  • Receptors, Interleukin-2